Eric Joseph Daniels - 20 Apr 2026 Form 3 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
21 Apr 2026, 17:00:06 UTC
Prior SEC filing
02 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Sims, attorney-in-fact

Key filing fact

Eric Joseph Daniels filed Form 3 for PLUS THERAPEUTICS, INC. (PSTV) on 21 Apr 2026.

Key facts

  • This page summarizes Eric Joseph Daniels's Form 3 filing for PLUS THERAPEUTICS, INC. (PSTV).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Apr 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 02 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001892943 Primary reporting owner

Daniels Eric Joseph

Relationship
Chief Development Officer
Address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
Signature
/s/ Andrew Sims, attorney-in-fact
Signature date
21 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PSTV holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
20 Apr 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .